Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Eur Spine J ; 17(12): 1671-5, 2008 Dec.
Article in English | MEDLINE | ID: mdl-18820953

ABSTRACT

Reduction of blood transfusions in patients with neuromuscular scoliosis can decrease potential complications such as immune suppression, infection, hemolytic reaction and viral transmission. Aprotinin (Trasylol), Bayer), an antifibrinolytic, has proven to be effective in reducing blood loss in cardiac and liver surgery, but little data exists in patients undergoing spinal fusion for neuromuscular scoliosis. The purpose of this study was to evaluate the safety and efficacy of aprotinin in pediatric neuromuscular scoliosis patients undergoing spinal fusion. The medical records of all patients undergoing initial spinal fusions for neuromuscular scoliosis between January 1999 and March 2003 were reviewed to determine demographic data, perioperative data, wound drainage and number of transfusion required. Cases were compared to a matched group of historical controls. We had 14 patients in the aprotinin group and 17 in the control group. Total blood loss in the aprotinin group was significantly lower compared to the control group (715 vs. 2,110 ml; P = 0.007). Significantly less blood loss occurred in the aprotinin group when blood loss per kilogram was evaluated as well (23 vs. 60 ml/kg, respectively; P = 0.002). Intra-operative packed red blood cell (PRBC) transfusions were also significantly lower in the aprotinin group (1.25 vs. 3.16 units; P = 0.001). No clinical evidence of anaphylaxis, deep vein thrombosis (DVT) or renal failure was observed in the aprotinin group. After considering the price of drug therapy, operating room time, and the cost of blood products, the use of aprotinin saved an average of $8,577 per patient. In our series, the use of aprotinin resulted in decreased blood loss and a decreased rate of transfusions in children with neuromuscular scoliosis undergoing extensive spinal fusion. At out institution, the use of aprotinin is safe and cost effective for patients with neuromuscular scoliosis.


Subject(s)
Aprotinin/administration & dosage , Blood Loss, Surgical/prevention & control , Hemostatics/administration & dosage , Intraoperative Complications/drug therapy , Neurosurgical Procedures/adverse effects , Scoliosis/surgery , Adolescent , Anaphylaxis/chemically induced , Aprotinin/adverse effects , Aprotinin/economics , Blood Loss, Surgical/statistics & numerical data , Blood Transfusion/economics , Blood Transfusion/statistics & numerical data , Case-Control Studies , Child , Cost-Benefit Analysis , Female , Health Care Costs/statistics & numerical data , Hemostasis, Surgical/economics , Hemostasis, Surgical/methods , Hemostasis, Surgical/statistics & numerical data , Hemostatics/adverse effects , Hemostatics/economics , Humans , Intraoperative Complications/prevention & control , Male , Neuromuscular Diseases/complications , Renal Insufficiency/chemically induced , Retrospective Studies , Scoliosis/etiology , Spinal Fusion/adverse effects , Thoracic Vertebrae/pathology , Thoracic Vertebrae/surgery , Transfusion Reaction , Treatment Outcome , Venous Thrombosis/chemically induced
2.
Paediatr Anaesth ; 16(1): 49-53, 2006 Jan.
Article in English | MEDLINE | ID: mdl-16409529

ABSTRACT

BACKGROUND: Nausea and vomiting is a common postoperative complication that often necessitates the use of antiemetic agents. METHODS: In a prospective, randomized, double blind trial, the effect of perioperative fluid administration on postoperative adverse outcomes following anesthesia was studied. One hundred children undergoing strabismus repair were randomly assigned to receive 10 ml x kg(-1) x h(-1) (control group) or 30 ml x kg(-1) x h(-1) (superhydration group) of lactated Ringer's solution during the operation. During the first 24 h postoperatively, nausea and vomiting, thirst, pain, and fever were evaluated. RESULTS: Groups were similar with respect to demographic data, surgical procedures and baseline hemodynamic variables. In the first 24 h postoperatively, nausea and vomiting occurred in 27 patients (54%) of the control group and 11 (22%) of patients in the superhydration group (P = 0.001). Comparison of the superhydration group with the control group also showed a statistically significant benefit of superhydration on postoperative thirst (P = 0.0002) and fever (P = 0.02). The differences in nausea and vomiting, thirst, and fever remained significant after adjustment for age, gender, weight, and duration of surgery. There was no significant difference between the two groups in postoperative pain. CONCLUSIONS: Intravenous superhydration administration is an inexpensive and safe therapy for reducing postoperative nausea and vomiting and discomfort.


Subject(s)
Fluid Therapy , Isotonic Solutions/therapeutic use , Postoperative Nausea and Vomiting/prevention & control , Child, Preschool , Double-Blind Method , Female , Humans , Isotonic Solutions/administration & dosage , Male , Postoperative Nausea and Vomiting/physiopathology , Ringer's Lactate , Strabismus/surgery
SELECTION OF CITATIONS
SEARCH DETAIL
...